ArticleBMC oral health2025
Killing effect of antibacterial photodynamic therapy with long-term exposure against young and mature Enterococcus faecalis biofilms in dentin.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Effectiveness of oxidative therapies in mature oral biofilms: A systematic review and meta-analysis.Clinical oral investigations · 2026Pooled it
- Membrane Vesicles ofMicroorganisms · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe main cause of pulpal and periapical diseases is bacterial infection, but mechanical and chemical preparation in root canal therapy is difficult to completely remove the bacterial microorganism. Antibacterial photodynamic therapy (aPDT) is a medical method that kills microorganisms by activating a photoactive agent or photosensitizer by exposure to visible light of a specific wave-length in the presence of oxygen. The present study aimed to evaluate the killing in vitro effect of aPDT with 0.01% methylene blue (MB) against young and mature Enterococcus faecalis (E. faecalis) biofilms in bovine and human dentin with the long-term exposure using confocal laser scanning microscopy (CLSM).
methodsPrepared bovine and human dentin blocks and their structure were observed by scanning electron microscopy (SEM). Semicylindrical bovine dentin blocks and human root canal dentin blocks were inoculated with E. faecalis and incubated in air to form 1- and 3-week-old biofilms. The biofilms in dentin were subjected to aPDT with 0.01% MB, 5% NaOCl and saline with the exposure of 3, 12 and 30 min. The dead portions of bacterial cells in E. faecalis biofilms were analyzed with using LIVE/DEAD bacteria viability staining and CLSM.
resultsA clean dentin surface in bovine dentin blocks were verified with SEM. In bovine and human dentin blocks, significantly more bacteria were dead when aPDT with MB and 5% NaOCl were used with the long exposure time (12 and 30 min) than with 3 min (P < 0.05). The speed of killing was fastest during the first 3 min, and few more bacterial cells were killed after 12 min in the disinfection groups. 5% NaOCl exhibited the highest effectiveness of bacterial killing in dentin at each time point than aPDT with MB groups (P < 0.05). The proportion of killed bacteria was higher in young biofilms than in mature biofilms in aPDT with MB and NaOCl groups (P < 0.05). Moreover, there were no clearly visible changes in structure of bovine dentin surfaces subjected to aPDT with MB for 30 min.
conclusionaPDT with 0.01% MB has the capability to kill bacterial cells in E. faecalis biofilms on bovine and human dentin blocks. Young E. faecalis biofilms in dentin canals were more susceptible to disinfection approaches than mature biofilms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.